Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma

from JAMA Otolaryngology–Head & Neck Surgery Author Interviews

Interview with Trisha M. Wise-Draper, MD, PhD author of Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD MBA. Related Content: Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma

Episode metadata supplied by the publisher feed · Published Mar 26, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma

0:00 11:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Otolaryngology–Head & Neck Surgery Author Interviews?

This episode is 11 minutes long.

When was this JAMA Otolaryngology–Head & Neck Surgery Author Interviews episode published?

This episode was published on March 26, 2026.

Can I download this JAMA Otolaryngology–Head & Neck Surgery Author Interviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!